ARTICLES BY THIS AUTHOR
- 12/16/2008
Stelara approved for psoriasis
Canada is the first country worldwide to approve Janssen-Ortho's Stelara for the treatment of psoriasis. - 12/11/2008
Survey: Side-effects a serious issue for CML patients
Many CML patients today are living with side effects so strong that their quality of life is greatly reduced, according to a survey by the CML Society of Canada. - 12/11/2008
U.K. to pilot pharmacist birth control prescribing
Pharmacists in London, England will receive authorization next year to supply women with the oral contraceptive pill over-the-counter-without the need for a doctor's prescription-as part of a new pilot project. - 12/10/2008
Canada-wide influenza information
Fightflu.ca is a new pan-Canadian portal designed to help prevent the spread of influenza and other infectious diseases. - 12/9/2008
Volibris for pulmonary arterial hypertension
GlaxoSmithKline's Volibris is a new endothelin receptor antagonist for the treatment of idiopathic (primary) pulmonary arterial hypertension, as well as PAH associated with connective tissue disease. - 12/5/2008
Survey looks at life with HIV/AIDS
Twenty-five years after the discovery of HIV, Canadians living with the illness carry a huge stigma and social isolation, according to recent research findings. - 12/4/2008
Nutritional calories from beverages decrease with age
Milk and juice start taking a backseat to soda, coffee and alcohol - 12/4/2008
Show CAMH patients you care
- 12/4/2008
Katz CEO to lead NACDS
Andrew Giancamilli, CEO of Katz Group North America and Snyder's Drug Stores, is the newly appointed chairman of the board of the NACDS,